230 Publications (Page 7 of 10)
2012
COMPARTMENTAL PHARMACOKINETICS (PK) OF IMMEDIATE RELEASE NIFEDIPINE (NIP) IN PREGNANCY: VARIABILITY IN ABSORPTION. Clinical Pharmacology & Therapeutics
. | Journal Article
 
GENOTYPE-BASED IN VITRO-IN VIVO EXTRAPOLATION (IVIVE) OF EFAVIRENZ PHARMACOKINETICS USING A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL
Xu, C.Quinney, S.Guo, Y. and Desta, Z.
Clinical Pharmacology & Therapeutics, vol. 91, pp. S30. | Journal Article
 
GENOTYPE-BASED IN VITRO-IN VIVO EXTRAPOLATION (IVIVE) OF EFAVIRENZ PHARMACOKINETICS USING A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL
Xu, C.Quinney, S.Guo, Y. and Desta, Z.
(pp. S30)
 
GENOTYPE-BASED IN VITRO-IN VIVO EXTRAPOLATION (IVIVE) OF EFAVIRENZ PHARMACOKINETICS USING A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL. Clinical Pharmacology & Therapeutics
. | Journal Article
 
GLOBAL ANALYSIS OF CYP3A4 AND CYP3A5 GENOTYPE ON IN VIVO CLEARANCE OF CYP3A4 SUBSTRATES.
Quinney, S. K.Schwartz, J. B.Hall, S. D.Gorski, J. C. and Li, L.
(pp. S49)
 
GLOBAL ANALYSIS OF CYP3A4 AND CYP3A5 GENOTYPE ON IN VIVO CLEARANCE OF CYP3A4 SUBSTRATES.
Quinney, S. K.Schwartz, J. B.Hall, S. D.Gorski, J. C. and Li, L.
Clinical Pharmacology & Therapeutics, vol. 91, pp. S49. | Journal Article
 
GLOBAL ANALYSIS OF CYP3A4 AND CYP3A5 GENOTYPE ON IN VIVO CLEARANCE OF CYP3A4 SUBSTRATES. Clinical Pharmacology & Therapeutics
. | Journal Article
 
Literature based drug interaction prediction with clinical assessment using electronic medical records: novel myopathy associated drug interactions.
Duke, Jon DHan, XuWang, ZhipingSubhadarshini, AbhinitaKarnik, Shreyas DLi, XiaochunHall, Stephen DJin, YanCallaghan, J TOverhage, Marcus JFlockhart, David AStrother, R MQuinney, Sara K and Li, Lang
PLoS computational biology, vol. 8, (no. 8), pp. e1002614, 2012. | Journal Article
 
Literature Based Drug Interaction Prediction with Clinical Assessment Using Electronic Medical Records: Novel Myopathy Associated Drug Interactions. PLOS Computational Biology
. | Journal Article
 
NOVEL TRANSLATIONAL PARADIGM FOR DRUG-DRUG INTERACTION RESEARCH: A COMBINATION OF LITERATURE-BASED DISCOVERY, ELECTRONIC MEDICAL RECORDS AND IN VITRO DDI SCREENING ASSAYS.
Han, X.Wang, Z.Subhadarshini, A.Karnik, S.Strother, R. M.Hall, S. D.Jin, Y.Flockhart, D. A.Quinney, S. K.Duke, J. D. and Li, L.
(pp. S2)
 
NOVEL TRANSLATIONAL PARADIGM FOR DRUG-DRUG INTERACTION RESEARCH: A COMBINATION OF LITERATURE-BASED DISCOVERY, ELECTRONIC MEDICAL RECORDS AND IN VITRO DDI SCREENING ASSAYS.
Han, X.Wang, Z.Subhadarshini, A.Karnik, S.Strother, R. M.Hall, S. D.Jin, Y.Flockhart, D. A.Quinney, S. K.Duke, J. D. and Li, L.
Clinical Pharmacology & Therapeutics, vol. 91, pp. S2. | Journal Article
 
NOVEL TRANSLATIONAL PARADIGM FOR DRUG-DRUG INTERACTION RESEARCH: A COMBINATION OF LITERATURE-BASED DISCOVERY, ELECTRONIC MEDICAL RECORDS AND IN VITRO DDI SCREENING ASSAYS. Clinical Pharmacology & Therapeutics
. | Journal Article
2011
Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia
Egbelakin, AkinbodeEgbelakin, AkinbodeFerguson, Michael JFerguson, Michael JMacGill, Emily AMacGill, Emily ALehmann, Amalia SLehmann, Amalia STopletz, Ariel RTopletz, Ariel RQuinney, Sara KQuinney, Sara KLi, LangLi, LangMcCammack, Kevin CMcCammack, Kevin CHall, Stephen DHall, Stephen DRenbarger, Jamie L and Renbarger, Jamie L
Pediatric Blood & Cancer, vol. 56, (no. 3), pp. 361-367, 2011. | Journal Article
 
Increased Risk of Vincristine Neurotoxicity Associated With Low CYP3A5 Expression Genotype in Children With Acute Lymphoblastic Leukemia. Pediatric Blood and Cancer
. | Journal Article
2010
AN AUTO-INHIBITION PHARMACOKINETICS MODEL FOR PARAXETINE.
Han, X.Quinney, S. K.Flockhart, D. A. and Li, L.
(pp. S53)
 
AN AUTO-INHIBITION PHARMACOKINETICS MODEL FOR PARAXETINE.
Han, X.Quinney, S. K.Flockhart, D. A. and Li, L.
Clinical Pharmacology & Therapeutics, vol. 87, pp. S53. | Journal Article
 
AN AUTO-INHIBITION PHARMACOKINETICS MODEL FOR PARAXETINE. Clinical Pharmacology & Therapeutics
. | Journal Article
 
Biomarkers in the prediction of vincristine metabolism and neuropathy in pediatric acute lymphoblastic leukemia patients. Journal of Clinical Oncology
. | Journal Article
 
Biomarkers in the prediction of vinerstine metabolism and neuropathy in pediatric acute lymphoblastic leukemia patients.
Lehmann, A. S.Egbelakin, A.Quinney, S. K.Li, L. and Renbarger, J. L.
 
Biomarkers in the prediction of vinerstine metabolism and neuropathy in pediatric acute lymphoblastic leukemia patients.
Lehmann, A. S.Egbelakin, A.Quinney, S. K.Li, L. and Renbarger, J. L.
Journal of Clinical Oncology, vol. 28. | Journal Article
 
Independent influence of dietary protein on markers of kidney function and disease in obesity.
Friedman, Allon NFriedman, Allon NYu, ZhangshengYu, ZhangshengJuliar, Beth EJuliar, Beth ENguyen, James TNguyen, James TStrother, MatthewStrother, MatthewQuinney, Sara KQuinney, Sara KLi, LangLi, LangInman, MargaretInman, MargaretGomez, GerardoGomez, GerardoShihabi, ZakShihabi, ZakMoe, Sharon and Moe, Sharon
Kidney international, vol. 78, (no. 7), pp. 693-7, 2010/Oct. | Journal Article
 
Independent influence of dietary protein on markers of kidney function and disease in obesity. Kidney International
. | Journal Article
 
Inhibition of CYP3A by erythromycin: in vitro-in vivo correlation in rats.
Zhang, XinGalinsky, Raymond EKimura, Robert EQuinney, Sara KJones, David R and Hall, Stephen D
Drug metabolism and disposition: the biological fate of chemicals, vol. 38, (no. 1), pp. 61-72, 2010/Jan. | Journal Article
 
Inhibition of CYP3A by Erythromycin: In Vitro-In Vivo Correlation in Rats. Drug Metabolism and Disposition
. | Journal Article
 
Measuring the glomerular filtration rate in obese individuals without overt kidney disease.
Friedman, AllonStrother, MatthewQuinney, Sara KHall, StephenPerkins, Susan MBrizendine, Edward JInman, MargaretGomez, GerardoShihabi, ZakMoe, Sharon and Li, Lang
Nephron. Clinical practice, vol. 116, (no. 3), pp. c224-34, 2010. | Journal Article